INSIGHTS ON SOLID DOSE MANUFACTURING
-
![GettyImages-485381432-beaker-with-water-and-tablets-pills-dissolving]( "A Simple And Powerful Solution For Accelerating Dissolution")
A Simple And Powerful Solution For Accelerating DissolutionMany poorly soluble drugs fail not because of low solubility, but because they dissolve too slowly. Learn how focusing on dissolution rate can unlock absorption gains using simple strategies.
-
![GettyImages-1194851415-OSD-oral-solid-tablet-pill-capsule]( "Reducing Uncertainty In Early Oral Drug Development")
Reducing Uncertainty In Early Oral Drug DevelopmentFive recurring decision points in early oral solid dose development carry outsized downstream consequences. AI/ML-driven predictive modeling is reframing how teams manage those decisions under API and timeline constraints.
-
![GettyImages-2176475661 tabet press, pharma manufacturing]( "Navigating High-Potency OSD Manufacturing")
Navigating High-Potency OSD ManufacturingLearn how containment strategy, process design, and early risk‑based decisions influence operator protection, compliance, and long‑term manufacturing success as potency levels continue to rise.
-
![tablets pills pharmaceutical-GettyImages-1389349565]( "From Powder To Robust Tablet With Less Material: Compaction Simulator Arrives At Ardena Ghent")
From Powder To Robust Tablet With Less Material: Compaction Simulator Arrives At Ardena GhentAdvanced compaction simulation predicts formulation performance and tablet strength with minimal material, streamlining scale-up and accelerating development to clinical manufacturing.
-
Fundamentals Of Power Blending Simulations2/26/2025
Predicting blending quality doesn't have to be a guessing game. Learn how to leverage virtual prototypes to make informed decisions and minimize costly trial-and-error in tablet manufacturing.
-
Rational Design And Material-sparing Strategies For Enabled Intermediates And Drug Products9/9/2026
A material-sparing strategy integrating formulation mapping, lab-scale spray drying, and compact screening can accelerate risk identification and inform first-round tablet formulation decisions for poorly soluble APIs.
-
Developing And Manufacturing Minitablets To Extend Drug Lifecycle1/27/2025
Pharmaceutical companies should leverage oral minitablets to extend drug lifecycles, optimize dosing, and improve patient-centric solutions while overcoming manufacturing challenges.
-
Beyond Development: Using Continuous Manufacturing To Accelerate OSD Commercialization8/31/2026
Hear firsthand insights from Douglas B. Hausner, Ph.D., Senior Manager of Continuous Manufacturing, on the company’s first OSD product submission enabled by continuous manufacturing and Real-Time Release Testing.
-
Segments: Next-Generation Tablet Press Technology10/7/2025
Segments increase press output by up to 25% and cut setup time by 88%. Learn the benefits, drawbacks, and manufacturing needs of this rapidly growing tablet press technology.
SOLID DOSE MANUFACTURING SOLUTIONS
-
![bottling mockup]( "Contract Solid Dose Bottling Services")
Providing customized solid-dose bottling solutions with agile production for a wide range of bottle sizes and shapes, flexible quantity requirements, and multiple cap types.
-
![Potent-Processing-GettyImages-2211653335]( "Potent Processing And Manufacture")
Highly potent compounds demand specialized containment, risk management, and manufacturing expertise to support safe, efficient development and scalable commercial production.
-
![Pharmaceutical-Sterility-Testing-isolators-from-Franz-Ziel]( "Pharmaceutical Sterility Testing Isolators From Franz Ziel")
Sterility testing isolators with product protection for the sterility test under aseptic and optionally aseptic/toxic conditions. A Rapid Decon Hatch (RDH) can be connected as an option.
-
![Esco - DFB still]( "Engineered Unidirectional Airflow For Reliable And Continuous Safety")
High-efficiency filtration and controlled airflow maintain a clean workspace, preventing cross-contamination and ensuring reliable containment across diverse industrial and laboratory applications.
-
![GettyImages-1405590436-lab-perfusion-cleanroom]( "Small Molecule Drug Substance: API Capabilities")
Eurofins CDMO Alphora handles small molecule APIs and HPAPIs from IND-enabling through commercialization, with FDA and Health Canada-approved facilities scaling up to 125 kg per batch. Contact them to discuss your program.
